IMANI CHISLEY-PITTMON: Open Payments
NPI 1679022420 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 19 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $556
Food & beverage: $456Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $346 |
| Sumitomo Pharma America, Inc. | 4 | $90 |
| PFIZER INC. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Organon LLC | 1 | $26 |
| Exeltis, USA Inc. | 1 | $25 |
Products named: Veozah, MYFEMBREE, ABRYSVO, Mirena, NEXPLANON, SLYND.
Industry payments across VA — which companies pay providers there.
